JP Morgan Maintains Overweight on MetLife, Raises Price Target to $110
JP Morgan analyst Pablo Singzon maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $108 to $110.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga